* Guardant Health Inc GH.OQ reported a quarterly adjusted
loss
of 84 cents per share for the quarter ended in June, lower
than the same quarter last year, when the company reported EPS
of -67 cents. The mean expectation of twenty two analysts for
the quarter was for a loss of 74 cents per share. Wall Street
expected results to range from -94 cents to -54 cents per share.
* Revenue rose 29.2% to $177.24 million from a year ago;
analysts
expected $162.70 million.
* Guardant Health Inc's reported EPS for the quarter was a
loss
of 84 cents.
* The company reported a quarterly loss of $102.63 million.
* Guardant Health Inc shares had risen by 11.4% this
quarter and
gained 18.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 8.7%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 21 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Guardant Health
Inc is $40.00
This summary was machine generated from LSEG data August 7 at
09:54 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 -0.74 -0.84 Missed
Mar. 31 2024 -0.85 -0.94 Missed
Dec. 31 2023 -0.86 -0.85 Beat
Sep. 30 2023 -0.94 -0.73 Beat